1. Funke G, von Graevenitz A, Clarridge JE 3rd, Bernard KA. Clinical microbiology of coryneform bacteria. Clin Microbiol Rev. 1997; 10:125–159. PMID:
8993861.
Article
2. Soriano F, Zapardiel J, Nieto E. Antimicrobial susceptibilities of
Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob Agents Chemother. 1995; 39:208–214. PMID:
7695308.
3. Funke G, Bernard KA. Murray PR, Baron EJ, editors. Coryneform gram-positive rods. Manual of clinical microbiology. 2007. 9th ed. Washington, DC: ASM Press;p. 485–514.
Article
4. Greisen K, Loeffelholz M, Purohit A, Leong D. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol. 1994; 32:335–351. PMID:
7512093.
Article
5. Sierra JM, Martinez-Martinez L, Vázquez F, Giralt E, Vila J. Relationship between mutations in the
gyrA gene and quinolone resistance in clinical isolates of
Corynebacterium striatum and
Corynebacterium amycolatum. Antimicrob Agents Chemother. 2005; 49:1714–1719. PMID:
15855486.
6. Gómez-Garcés JL, Alos JI, Tamayo J. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria. Int J Antimicrob Agents. 2007; 29:688–692. PMID:
17475450.
Article